Tarvanib

Tarvanib 150 mg Introduction

Tarvanib 150 mg is a type of medication that is prescribed to treat non-small cell lung cancer (NSCLC). It is an orally administered drug and belongs to the tyrosine kinase inhibitor (TKI) class of medications. Tarvanib 150 mg works by inhibiting the epidermal growth factor receptor (EGFR) in cancer cells, preventing them from growing and spreading.

Uses for Tarvanib 150 mg

Tarvanib 150 mg is used to treat advanced or metastatic non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It is used along with other cancer treatments, such as chemotherapy, and may be prescribed after other cancer drugs have failed, when other treatments have become less effective, or if the cancer has spread to other parts of the body.

Mechanism of Action of Tarvanib 150 mg

Tarvanib 150 mg works by inhibiting the epidermal growth factor receptor (EGFR) that is found on the surface of some types of cancer cells. When EGFR is blocked, growth of the tumor is inhibited. This helps slow the growth and spread of the cancer in the body.

How Long Does it Take for Tarvanib 150 mg to Work?

It can take weeks or months for erlotinib to work. Generally, the longer a person takes the medication, the better the response. Some people will experience improvement in symptoms within a few weeks, while other people may not feel a change in their symptoms until after several months.

Absorption of Tarvanib 150 mg

Tarvanib 150 mg is absorbed quickly and within 1 to 2 hours of taking it, 60 to 70% of it can be detected in the blood. After absorption, it binds to proteins in the blood and is then distributed to different parts of the body.

Route of Elimination of Tarvanib 150 mg

The route of elimination for erlotinib is mainly through the urine and feces within 2 to 3 days. A small amount is excreted in the bile.

Dosage of Tarvanib 150 mg

The dosage of erlotinib depends on the patient’s body weight, the stage of disease, and other medications being used to treat cancer. Generally, the recommended dosage is 150mg taken orally once daily. This should be taken on an empty stomach at least 1 hour before or 2 hours after meals.

Administration of Tarvanib 150 mg

Tarvanib 150 mg is administered as an oral drug. It can be taken with or without food, although it is best to take erlotinib at least 1 hour before or 2 hours after meals. The tablets should be taken as a whole and not crushed or chewed.

Side Effects of Tarvanib 150 mg

Common side effects of erlotinib include skin rash, stomach discomfort or pain, nausea, vomiting, headache, fatigue, loss of appetite, and diarrhea. In rare cases, serious side effects such as liver damage, severe rash, breathing difficulty, and eye irritation can occur. Tell your doctor immediately if any of these side effects occur.

Toxicity of Tarvanib 150 mg

Tarvanib 150 mg is generally well tolerated, but it can cause serious and life-threatening side effects. Liver toxicity is one of the most serious side effects and can lead to liver failure. It is important to tell your doctor immediately if you experience any of the above mentioned side effects.

Precaution for Taking Tarvanib 150 mg

1. Tell your doctor if you have any pre-existing medical conditions, such as liver, kidney, or heart problems before taking erlotinib.
2. Your doctor may order regular blood tests while taking erlotinib, to monitor your liver function.
3. Tarvanib 150 mg can cause a skin rash, so avoid excessive sun exposure.
4. Do not take any other medications while taking erlotinib without your doctor’s approval.

Interaction with Diseases

Tarvanib 150 mg should not be taken by people with severe kidney and liver diseases or those taking medications that can affect the liver or kidney. It may also interact with other drugs and should not be taken by people who are taking other medications that can affect the liver or kidneys. Tell your doctor about all the medication you are taking.

Drug Interactions of Tarvanib 150 mg

Tarvanib 150 mg can interact with other drugs, such as antacids, antibiotics, steroids, and drugs used to treat seizures or depression. It can also interact with some over-the-counter medications and herbal supplements. Tell your doctor about all the medications and supplements that you are taking.

Food Interactions of Tarvanib 150 mg

Tarvanib 150 mg can interact with some foods, including dairy products, grapefruit juice, and drinks containing caffeine. Grapefruit juice can increase the amount of erlotinib in the body, so it is best to avoid all grapefruit products while taking erlotinib.

Pregnancy and Lactation Use of Tarvanib 150 mg

Tarvanib 150 mg should not be used during pregnancy because it can cause harm to the fetus. It is also not recommended for lactating mothers, as it can pass into breast milk. Consult with your doctor about other treatments available if you are pregnant or lactating.

Acute Overdose of Tarvanib 150 mg

An overdose of erlotinib can be life-threatening and should be treated as a medical emergency. Symptoms of overdose include nausea, vomiting, stomach pain, confusion, drowsiness, and weak or shallow breathing. Seek medical attention if you think you have overdosed on erlotinib.

Contraindication of Tarvanib 150 mg

Tarvanib 150 mg is contraindicated in people with pre-existing liver, kidney, or heart diseases. It should also not be used in people who are pregnant or lactating. People taking other medications that can affect the liver, kidneys, or heart should not take erlotinib.

Use Direction of Tarvanib 150 mg

Take erlotinib exactly as prescribed by your doctor. Do not change your dosage or stop taking it without your doctor’s approval. Take erlotinib at least 1 hour before or 2 hours after meals, and swallow the whole tablet. Do not crush or chew the tablets.

Storage of Tarvanib 150 mg

Tarvanib 150 mg tablets should be stored at room temperature, away from moisture and heat, and in their original container. Keep the tablets out of reach of children and pets.

Volume of Distribution of Tarvanib 150 mg

The volume of distribution of erlotinib is approximately 12.6 L/kg. This means that the drug is evenly distributed throughout the body when taken.

Half Life of Tarvanib 150 mg

The half life of erlotinib is approximately 14.7 hours. This means that, after 14.7 hours, the amount of erlotinib in the body is reduced by half.

Clearance of Tarvanib 150 mg

The clearance of erlotinib is approximately 89 mL/min. This means that the drug is eliminated from the body at an average rate of 89 mL/min.

See in details version Tarvanib 150 mg also Tarvanib 150 mg in bangla

Some Frequently Asked Questions About Tarvanib 150 mg